Skip to main content
$2.19 -$0.06 (-2.7%)

04:00 PM EDT on 09/21/23

Fate Therapeutics (NASDAQ:FATE)

CAPS Rating: 5 out of 5

Current Price $2.19 Mkt Cap $221.8M
Open $2.21 P/E Ratio -1.01
Prev. Close $2.19 Div. (Yield) $0.00 (0.0%)
Daily Range $2.11 - $2.23 Volume 2,706,775
52-Wk Range $2.11 - $23.96 Avg. Daily Vol. 2,347,835

Caps

How do you think NASDAQ:FATE will perform against the market?

Add Stock to CAPS Watchlist

All Players

56 Outperform
2 Underperform
 

All-Star Players

6 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:FATE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Checkmating2021 (< 20)
Submitted September 01, 2021

It’s got the Boomstick Baby

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:FATE Summary

Fools bullish on NASDAQ:FATE are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about FATE.

Recs

1
Member Avatar Checkmating2021 (< 20) Submitted: 9/1/2021 5:04:08 PM : Outperform Start Price: $76.10 NASDAQ:FATE Score: -92.28

It’s got the Boomstick Baby

Recs

1
Member Avatar ted368 (< 20) Submitted: 10/6/2020 1:51:34 PM : Outperform Start Price: $41.89 NASDAQ:FATE Score: -121.34

Solid Partner in product and development.

Recs

0
Member Avatar NoPlaceLikeHome (< 20) Submitted: 3/9/2017 10:28:18 AM : Outperform Start Price: $4.09 NASDAQ:FATE Score: -128.52

With a phase 3 trial that can support an FDA application for approval of Zilretta, a non-opioid therapy for knee pain in osteoarthritis patients, under their belt, they are on the road to final approval. Long story short, if it gets the FDA green light, 10% market penetration is over $1B in revenue. It is non-opiod which means prescribers and patients do not have to hassle with increased scrutiny writing and filling scripts and I believe that will make market penetration very easy. At under $200 million in market cap and a $1B+ opportunity, I can't pass up the risk/reward. Buy!!

Leaderboard

Find the members with the highest scoring picks in FATE.

Score Leader

headyinvestor

headyinvestor (< 20) Score: +1,244.40

The Score Leader is the player with the highest score across all their picks in FATE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Origin97 32.92 4/15/2014 Underperform NS $7.58 -71.11% +135.32% +206.43 0 Comment
MMCapitalMgmt 99.96 5/11/2015 Underperform 5Y $7.40 -70.41% +103.90% +174.30 0 Comment
Under5 56.15 8/24/2023 Outperform 5Y $2.59 -15.28% -1.66% -13.62 0 Comment
curmie 34.13 3/22/2023 Outperform 5Y $5.42 -59.59% +8.19% -67.79 0 Comment
stainsolution < 20 2/17/2016 Outperform 5Y $1.57 +39.94% +123.68% -83.74 0 Comment
foggs1 60.78 3/30/2022 Outperform 5Y $41.20 -94.68% -6.29% -88.40 0 Comment
Kuddel55 < 20 12/6/2021 Outperform 5Y $47.18 -95.36% -6.09% -89.27 0 Comment
Caprese < 20 10/22/2021 Outperform 5Y $58.23 -96.24% -4.91% -91.33 0 Comment
Checkmating2021 < 20 9/2/2021 Outperform 5Y $76.10 -97.12% -4.84% -92.28 1 Comment
sorrycharlie1 61.67 3/1/2022 Outperform 5Y $35.18 -93.77% -0.84% -92.94 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FATE.